Keyphrases
Acute Myeloid Leukemia
16%
AIMS™
8%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
B Cells
58%
CD-8
25%
CD4 Cells
41%
Clinical Decision-making
8%
Clinically Significant
8%
Confidence Interval
41%
Cox Proportional Hazards
8%
Disease Relapse
8%
Fine-Gray Model
8%
Graft-versus-host Disease (GvHD)
25%
Hazard Ratio
41%
HCT Outcomes
8%
Hematological Malignancies
16%
Immune Reconstitution
100%
Institutional Analysis
100%
Large Cohort
8%
Leukemia Disease
8%
Leukemia Relapse
8%
Log-rank Statistic
8%
Low Risk
8%
Lymphocyte Subsets
8%
Martingale Residuals
8%
Natural Killer Cells
25%
Non-relapse Mortality
41%
Older Adults
8%
Reconstitution
8%
Relapse Risk
8%
Residual Plot
8%
Risk Model
8%
Risk Stratification
8%
Medicine and Dentistry
Acute Graft Versus Host Disease
8%
Acute Myeloid Leukemia
16%
B Cell
58%
CD8 Antigen
25%
Chronic Graft Versus Host Disease
8%
Clinical Decision Making
8%
Disease
8%
Graft Versus Host Reaction
8%
Hazard Ratio
41%
Hematologic Malignancy
16%
Hematopoietic Cell
100%
Immune Reconstitution
100%
Leukemia Relapse
8%
Lymphocyte Subpopulation
8%
Natural Killer Cell
25%
Non-Relapse Mortality
41%
Risk Stratification
8%
Transplantation
100%
Immunology and Microbiology
Acute Graft Versus Host Disease
8%
B Cell
58%
CD4
75%
CD8
25%
Chronic Graft Versus Host Disease
8%
Clinical Decision Making
8%
Graft-Versus-Host Disease
8%
Hematopoietic Cell
100%
Immune Reconstitution
100%
Lymphocyte Subpopulation
8%
Myeloid
16%
Natural Killer Cell
25%
